資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth

  • LinkedIn
  • facebook
  • Twitter
出 版 商:GBI Research
出版日期:2012/07/31
頁  數:103頁
文件格式:PDF
價  格:
USD 3,500 (Single-User License)
USD 7,000 (Multi-User License)
USD 10,500 (Global-User License)
線上訂購或諮詢
Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth

Summary

GBI Research’s report, “Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth”, provides key data, information and analysis on the global neurostimulation devices market. The report provides the market landscape, competitive landscape and market trend information on five neurostimulation device market segments: cortical stimulators, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators and vagus nerve stimulators. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products in each segment. It also reviews details about important merger and acquisition deals that have taken place in the neurostimulation devices market during the past five years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- The market size of five neurostimulation device market segments: cortical stimulators, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators and vagus nerve stimulators.
- Annualized market revenue data from 2004 to 2011, forecast forward for seven years to 2018.
- Qualitative analysis of key market trends, market drivers and restraints for each segment within the neurostimulation devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
- Key players covered include: Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and Cyberonics, Inc.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market entry and market expansion strategies.
- Identify key players best positioned to take advantage of emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- What’s the next big thing in the neurostimulation devices market landscape? Identify, understand and capitalize.
- Make more informed business decisions with the aid of insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 12
3 Global Neurostimulation Devices Market - An Overview 13
3.1 Spinal Cord Stimulator 13
3.2 Deep Brain Stimulator 13
3.3 Vagus Nerve Stimulator 13
3.4 Sacral Nerve Stimulator 13
3.5 Cortical Stimulator 13
4 Global Neurostimulation Devices Market - Market Characterization 14
4.1 Global Neurostimulation Devices Market, Revenue ($m), 2004-2011 14
4.2 Global Neurostimulation Devices Market, Revenue ($m), 2011-2018 15
4.3 Global Neurostimulation Devices Market, Key Company Share (%), 2010 17
4.4 Global Neurostimulation Devices Market: Key Trends 18
4.4.1 Application of Neurostimulation Technology for Treatment with New Therapies 18
4.4.2 Increasing Investments by Private Equity and Venture Capital Firms in Start-up Companies 19
4.5 Global Neurostimulation Devices Market: Market Dynamics 20
4.5.1 Market Drivers 20
4.5.2 Market Restraints 22
5 Global Neurostimulation Devices Market: Segment Analysis and Forecasts 24
5.1 Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 24
5.2 Spinal Cord Stimulators Market, Global, Revenue ($m), 2011-2018 25
5.3 Spinal Cord Stimulators: Market Dynamics 26
5.3.1 Market Drivers 26
5.3.2 Market Restraints 27
5.4 Deep Brain Stimulators Market, Global, Revenue ($m), 2004-2011 27
5.5 Deep Brain Stimulators Market, Global, Revenue ($m), 2011-2018 29
5.6 Deep Brain Stimulators: Market Dynamics 30
5.6.1 Market Drivers 30
5.6.2 Market Restraints 30
5.7 Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 31
5.8 Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 32
5.9 Vagus Nerve Stimulators: Market Dynamics 33
5.9.1 Market Drivers 33
5.9.2 Market Restraints 33
5.10 Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 34
5.11 Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 35
5.12 Sacral Nerve Stimulators: Market Dynamics 36
5.12.1 Market Drivers 36
5.12.2 Market Restraints 36
5.13 Cortical Stimulators Market, Global, Revenue ($m), 2004-2011 37
5.14 Cortical Stimulators Market, Global, Revenue ($m), 2011-2018 38
5.15 Cortical Stimulators: Market Dynamics 39
5.15.1 Market Drivers 39
5.15.2 Market Restraints 39
6 Global Neurostimulation Devices Market - Country Analysis and Forecasts 40
6.1 Neurostimulation Devices Market: Cross Country Analysis 40
6.2 Historic and Forecast Revenue, By Country 41
6.2.1 Neurostimulation Devices Market, the US, Revenue ($m), 2004-2011 41
6.2.2 Neurostimulation Devices Market, the US, Revenue ($m), 2011-2018 43
6.2.3 Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 44
6.2.4 Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 45
6.2.5 Neurostimulation Devices Market, the UK, Revenue ($m), 2004-2011 46
6.2.6 Neurostimulation Devices Market, the UK, Revenue ($m), 2011-2018 47
6.2.7 Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 48
6.2.8 Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 49
6.2.9 Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 50
6.2.10 Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 51
6.2.11 Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 52
6.2.12 Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 53
6.2.13 Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 54
6.2.14 Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 55
6.2.15 Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 56
6.2.16 Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 57
6.2.17 Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 58
6.2.18 Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 59
6.2.19 Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 60
6.2.20 Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 61
6.2.21 Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 62
6.2.22 Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 63
6.2.23 Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 64
6.2.24 Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 65
7 Global Neurostimulation Devices Market - Competitive Assessment 66
7.1 Medtronic, Inc. 66
7.1.1 Business Overview 66
7.1.2 Key Marketed Products 67
7.2 St. Jude Medical, Inc. 68
7.2.1 Business Overview 68
7.2.2 Key Marketed Products 68
7.3 Boston Scientific Corporation 69
7.3.1 Business Overview 69
7.3.2 Key Marketed Products 69
7.4 Cyberonics, Inc. 70
7.4.1 Business Overview 70
7.4.2 Key Marketed Products 70
8 Global Neurostimulation Devices Market: Pipeline Analysis 71
8.1 Introduction 71
8.1.1 Neurostimulation Devices: Pipeline Assessment, by Segment 71
8.1.2 Neurostimulation Devices: Pipeline Assessment, by Stage of Development 72
8.1.3 Neurostimulation Devices: Pipeline Assessment 73
8.2 Spinal Cord Stimulators: Product Pipeline 73
8.2.1 Spinal Cord Stimulators: List of Pipeline Products 73
8.2.2 Spinal Cord Stimulators: Profiles of Key Pipeline Products 74
8.3 Deep Brain Stimulators: Product Pipeline 77
8.3.1 Deep Brain Stimulators: List of Pipeline Products 77
8.3.2 Deep Brain Stimulators: Profiles of Key Pipeline Products 78
8.4 Vagus Nerve Stimulators: Product Pipeline 82
8.4.1 Vagus Nerve Stimulators: List of Pipeline Products 82
8.4.2 Vagus Nerve Stimulators: Profiles of Key Pipeline Products 83
8.5 Sacral Nerve Stimulators: Product Pipeline 85
8.5.1 Sacral Nerve Stimulators: List of Pipeline Products 85
8.5.2 Sacral Nerve Stimulators: Profiles of Key Pipeline Products 85
8.6 Cortical Stimulators: Product Pipeline 87
8.6.1 Cortical Stimulators: List of Pipeline Products 87
8.6.2 Cortical Stimulators: Profiles of Key Pipeline Products 87
8.7 Other Neurostimulation Devices - Product Pipeline 88
8.7.1 Other Neurostimulation Devices - List of Pipeline Products 88
9 Global Neurostimulation Devices Market - Consolidation Landscape 91
9.1 Neurostimulation Devices Market: Deals by Number and Deal Value, 2007-2012 91
9.2 Key Mergers and Acquisitions 2012 (Q1, Q2) 92
9.2.1 Greatbatch Acquires NeuroNexus Technologies 92
9.3 Key Mergers and Acquisitions: 2007-2011 93
9.3.1 Boston Scientific’s Acquisition of Intelect Medical 93
9.3.2 Otto Bock HealthCare’s Acquisition of Neurostream Technologies from Victhom Human Bionics 93
9.3.3 St. Jude Medical’s Acquisition of Northstar Neuroscience 94
9.3.4 Medtronic’s Acquisition of NDI’s Medstim System 94
9.3.5 Greatbatch’s Acquisition of Quan Emerteq 94
9.3.6 Greatbatch’s Acquisition of Enpath Medical 94
9.4 Key Partnership Deals: 2007-2010 95
9.4.1 EndoStim’s Agreement with Arizona State University 95
9.4.2 Ardiem Medical’s Licensing Agreement with Case Western Reserve University 95
9.4.3 Neurowave Medical Technologies’ Licensing Agreement with Alaven Pharma 96
9.4.4 Cyberonics’ Licensing Agreement with NeuroVista 96
9.4.5 Victhom Human Bionics’ Joint Venture Agreement with Otto Bock HealthCare 96
9.4.6 Cyberonics’ Agreement with Nihon Kohden 96
9.4.7 Cyberonics’ Licensing Agreement with Massachusetts Institute of Technology 96
9.4.8 NeuroNexus Technologies’ Research Agreement with Philips Research 96
9.4.9 Intelect Medical’s Agreement with Boston Scientific 97
9.4.10 Cyberonics’ Licensing Agreement with Southern Illinois University 97
9.4.11 Cyberonics’ Licensing Agreement with Ethicon Endo-Surgery 97
9.4.12 Innovative Neurotronics’ Agreement with Teijin Pharma 97
10 Appendix 98
10.1 Definitions 98
10.1.1 Neurostimulation Devices 98
10.1.2 Prevalence or Diseased Population 98
10.2 Sources 98
10.3 Acronyms 99
10.4 Research Methodology 101
10.4.1 Secondary Research 101
10.4.2 Primary Research 101
10.4.3 Models 102
10.4.4 Forecasts 102
10.4.5 Expert Panels 102
10.5 Contact Us 102
10.6 Disclaimer 103

1.1 List of Tables
Table 1: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 14
Table 2: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 16
Table 3: Neurostimulation Devices Market, Global, Key Company Revenue ($m), 2010 17
Table 4: Neurostimulation Devices Market, Global, Private Equity and Venture Capital Deals, 2011-2012 19
Table 5: Neurostimulation Devices Market, Global, Product Approvals, 2011 21
Table 6: Neurostimulation Devices Market, Global, Product Recalls, 2010-2012 22
Table 7: Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 24
Table 8: Spinal Cord Stimulators Market, Global, Revenue ($m), 2011-2018 25
Table 9: Deep Brain Stimulators Market, Global, Revenue ($m), 2004-2011 28
Table 10: Deep Brain Stimulators Market, Global, Revenue ($m), 2011-2018 29
Table 11: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 31
Table 12: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 32
Table 13: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 34
Table 14: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 35
Table 15: Cortical Stimulators Market, Global, Revenue ($m), 2004-2011 37
Table 16: Cortical Stimulators Market, Global, Revenue ($m), 2011-2018 38
Table 17: Neurostimulation Devices Market: Cross Country Analysis, Global, CAGR (%), 2004-2018 40
Table 18: Neurostimulation Devices Market, the US, Revenue ($m), 2004-2011 42
Table 19: Neurostimulation Devices Market, the US, Revenue ($m), 2011-2018 43
Table 20: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 44
Table 21: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 45
Table 22: Neurostimulation Devices Market, the UK, Revenue ($m), 2004-2011 46
Table 23: Neurostimulation Devices Market, the UK, Revenue ($m), 2011-2018 47
Table 24: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 48
Table 25: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 49
Table 26: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 50
Table 27: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 51
Table 28: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 52
Table 29: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 53
Table 30: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 54
Table 31: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 55
Table 32: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 56
Table 33: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 57
Table 34: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 58
Table 35: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 59
Table 36: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 60
Table 37: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 61
Table 38: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 62
Table 39: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 63
Table 40: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 64
Table 41: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 65
Table 42: Neurostimulation Devices Market, Global, Key Marketed Products - Medtronic, 2012 67
Table 43: Neurostimulation Devices Market, Global, Key Marketed Products - St. Jude Medical, 2012 68
Table 44: Neurostimulation Devices Market, Global, Key Marketed Products - Boston Scientific, 2012 69
Table 45: Neurostimulation Devices Market, Global, Key Marketed Products - Cyberonics, 2012 70
Table 46: Neurostimulation Devices Market, Global, Pipeline Analysis, by Segment, 2012 71
Table 47: Neurostimulation Devices Market, Global, Pipeline Analysis, by Stage of Development, 2012 72
Table 48: Neurostimulation Devices Market, Spinal Cord Stimulators, Global, List of Pipeline Products, 2012 73
Table 49: Neurostimulation Devices Market, Pipeline Analysis - PrimeADVANCED, 2012 74
Table 50: Neurostimulation Devices Market, Pipeline Analysis - Genesis Neurostimulation System, 2012 74
Table 51: Neurostimulation Devices Market, Pipeline Analysis - SAINT System, 2012 75
Table 52: Neurostimulation Devices Market, Global, Pipeline Analysis - Next Generation SCS System, 2012 75
Table 53: Neurostimulation Devices Market, Pipeline Analysis - Precision Plus SCS System, 2012 76
Table 54: Neurostimulation Devices Market, Deep Brain Stimulators, Global, List of Pipeline Products, 2012 77
Table 55: Neurostimulation Devices Market, Pipeline Analysis - Activa PC, 2012 78
Table 56: Neurostimulation Devices Market, Pipeline Analysis - CR-Capable Implant, 2012 78
Table 57: Neurostimulation Devices Market, Pipeline Analysis - Enspire DBS Therapy System, 2012 78
Table 58: Neurostimulation Devices Market, Pipeline Analysis - ESStim 101, 2012 79
Table 59: Neurostimulation Devices Market, Pipeline Analysis - Libra Deep Brain Stimulation System, 2012 79
Table 60: Neurostimulation Devices Market, Pipeline Analysis - Vercise DBS System, 2012 80
Table 61: Neurostimulation Devices Market, Pipeline Analysis - directSTIM, 2012 80
Table 62: Neurostimulation Devices Market, Pipeline Analysis - spiderSTIM, 2012 80
Table 63: Neurostimulation Devices Market, Pipeline Analysis - Synapse, 2012 81
Table 64: Neurostimulation Devices Market, Vagus Nerve Stimulators, Global, List of Pipeline Products, 2012 82
Table 65: Neurostimulation Devices Market, Pipeline Analysis - Aspire NP, 2012 83
Table 66: Neurostimulation Devices Market, Pipeline Analysis- FitNes System, 2012 84
Table 67: Neurostimulation Devices Market, Pipeline Analysis - SAINT System, 2012 84
Table 68: Neurostimulation Devices Market, Pipeline Analysis - NEMOS, 2012 84
Table 69: Neurostimulation Devices Market, Pipeline Analysis - Pulse Generator, 2012 85
Table 70: Neurostimulation Devices Market, Sacral Nerve Stimulators, Global, List of Pipeline Products, 2012 85
Table 71: Neurostimulation Devices Market, Pipeline Analysis - Sacral Nerve Stimulation Device, 2012 85
Table 72: Neurostimulation Devices Market, Pipeline Analysis - SAINT System, 2012 86
Table 73: Neurostimulation Devices Market, Pipeline Analysis - Verv System, 2012 86
Table 74: Neurostimulation Devices Market, Cortical Stimulators, Global, List of Pipeline Products, 2012 87
Table 75: Neurostimulation Devices Market, Pipeline Analysis - cortiSTIM, 2012 87
Table 76: Neurostimulation Devices Market, Other Neurostimulation Devices, Global, List of Pipeline Products, Table 1, 2012 88
Table 77: Neurostimulation Devices Market, Other Neurostimulation Devices, Global, List of Pipeline Products, Table 2, 2012 89
Table 78: Neurostimulation Devices Market, Other Neurostimulation Devices, Global, List of Pipeline Products, Table 3, 2012 90
Table 79: Neurostimulation Devices Market, Global, Key Mergers and Acquisitions, by Number of Deals and Deal Value ($m), 2007-2012 92
Table 80: Neurostimulation Devices Market, Global, Key Mergers and Acquisitions, 2007-2011 93
Table 81: Neurostimulation Devices Market, Global, Key Partnership Deals, 2007-2010 95

1.2 List of Figures
Figure 1: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 14
Figure 2: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 15
Figure 3: Neurostimulation Devices Market, Global, Key Company Share (%), 2010 17
Figure 4: Neurostimulation Devices Market, Potential for the Treatment of Various Indications, 2012 18
Figure 5: Neurostimulation Devices Market, Global, Population of Elderly (%), By 2020 21
Figure 6: Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 24
Figure 7: Spinal Cord Stimulators Market, Global, Revenue ($m), 2011-2018 25
Figure 8: Deep Brain Stimulators Market, Global, Revenue ($m), 2004-2011 27
Figure 9: Deep Brain Stimulators Market, Global, Revenue ($m), 2011-2018 29
Figure 10: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 31
Figure 11: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 32
Figure 12: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 34
Figure 13: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 35
Figure 14: Cortical Stimulators Market, Global, Revenue ($m), 2004-2011 37
Figure 15: Cortical Stimulators Market, Global, Revenue ($m), 2011-2018 38
Figure 16: Neurostimulation Devices Market: Cross Country Analysis, Global, CAGR (%), 2004-2018 40
Figure 17: Neurostimulation Devices Market, the US, Revenue ($m), 2004-2011 41
Figure 18: Neurostimulation Devices Market, the US, Revenue ($m), 2011-2018 43
Figure 19: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 44
Figure 20: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 45
Figure 21: Neurostimulation Devices Market, the UK, Revenue ($m), 2004-2011 46
Figure 22: Neurostimulation Devices Market, the UK, Revenue ($m), 2011-2018 47
Figure 23: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 48
Figure 24: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 49
Figure 25: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 50
Figure 26: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 51
Figure 27: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 52
Figure 28: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 53
Figure 29: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 54
Figure 30: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 55
Figure 31: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 56
Figure 32: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 57
Figure 33: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 58
Figure 34: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 59
Figure 35: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 60
Figure 36: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 61
Figure 37: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 62
Figure 38: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 63
Figure 39: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 64
Figure 40: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 65
Figure 41: Neurostimulation Devices Market, Global, Competitive Assessment, 2012 66
Figure 42: Neurostimulation Devices Market, Global, Pipeline Analysis, by Segment (%), 2012 71
Figure 43: Neurostimulation Devices Market, Global, Pipeline Analysis, by Stage of Development (%), 2012 72
Figure 44: Neurostimulation Devices Market, Global, Pipeline Assessment, Analytics Framework, 2012 73
Figure 45: Neurostimulation Devices Market, Global, Key Mergers and Acquisitions, by Number of Deals and Deal Value ($m), 2007-2012 91
回上頁